Multiple-dose Pharmacokinetics
Multiple-Dose Pharmacokinetics is a subdiscipline of pharmacokinetic analysis that characterizes the absorption, distribution, metabolism, and excretion of a drug following repeated administrations, distinguished by its focus on steady-state behavior, accumulation, and time-concentration profiles under sustained dosing regimens.
2.3K
Publications
106K
Citations
10.2K
Authors
2.1K
Institutions
Publications per year
2017–2026
255
2.3K
1–5 of 2.3K
10.2K
16
h-index
14
h-index
13
h-index
Bristol-Myers Squibb (United States), United States
14 publications · 577 citations
13
h-index
13
h-index
1–5 of 10.2K
2.1K
Pfizer (United States)
New York, United States
32 h-index
229 publications
20.1K citations
Bristol-Myers Squibb (United States)
New York, United States
28 h-index
270 publications
10K citations

Research Triangle Park Foundation
Durham, United States
25 h-index
152 publications
9.3K citations
Roche (Switzerland)
Basel, Switzerland
25 h-index
142 publications
7.8K citations
Bristol-Myers Squibb (Germany)
Munich, Germany
24 h-index
152 publications
6.6K citations
University at Buffalo, State University of New York
Buffalo, United States
23 h-index
86 publications
4.6K citations
Abbott Fund
Chicago, United States
22 h-index
126 publications
6.8K citations
Eli Lilly (United States)
Indianapolis, United States
21 h-index
107 publications
8.3K citations
1–8 of 2.1K
AAC · 171 publications · 11.5K citations
61
h-index
264 publications · 11.5K citations
55
h-index
CPT · 125 publications · 8.5K citations
51
h-index
BJCP · 151 publications · 7K citations
45
h-index
71 publications · 3.4K citations
37
h-index
1–5